Initial funding for HT2 came from the Michigan Health Endowment Fund through awards to Wayne State University and to the Michigan Department of Health and Human Services (MDHHS), with additional funding from the Blue Cross Blue Shield of Michigan Foundation awarded to Munson Healthcare. HT2 technology is currently being expanded throughout Michigan with funds from the Substance Abuse and Mental Health Services Administration, awarded through the Maternal and Infant Health Division of MDHHS. The research behind HT2 technology was supported by awards from the National Institutes of Health (DA000516, DA014621, DA021329, DA018975, DA021668, DA029050, AA020056, DA036788, and AA26596) and from the Centers for Disease Control and Prevention (CE001078, DP006082, and NU84DD00001). The software platform supporting HT2 technology (the Computerized Intervention Authoring System version 3.0) was built under an active award from NIH/The National Institute of Biomedical Imaging and Bioengineering (EB028990). The MC3 Perinatal Expansion project is funded by Healthy Moms, Healthy Babies through the Michigan Department of Health and Human Services.